NASDAQ:ARTV | Cash Flow Statement | Artiva Biotherapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$25.01M
2026-03-31-$23.52M$666,000.00-$20.95M$242,000.00$15.32M-$112,000.00
2025-12-31-$20.77M$666,000.00-$14.73M$421,000.00$16.04M-$121,000.00
2025-09-30-$21.53M
2025-06-30-$21.25M
2025-03-31-$20.31M$628,000.00-$19.84M$511,000.00$9.97M$239,000.00
2024-12-31-$16.1M$614,000.00-$14.65M$64,000.00-$966,000.00-$30,000.00
2024-09-30-$17.47M
2024-06-30-$17.84M
2024-03-31-$13.96M$587,000.00-$15.09M$18,000.00$9.78M
2023-12-31-$12M$594,000.00-$10.68M$636,000.00-$2.67M$962,000.00
2023-09-30$11.28M
2023-06-30-$11.28M
2023-03-31-$16.72M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$83.87M$2.6M-$76.75M$2.59M$63.41M$9,000.00
2024-12-31-$65.37M$2.43M-$55.03M$642,000.00-$120.46M$162.23M
2023-12-31-$28.72M$2.27M-$47.43M$3.26M-$25.98M$24.39M